Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plerixafor for HSC Mobilization in Sickle Cell Disease
NCT02212535Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2016
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of plerixafor in sickle cell disease (SCD), sponsored by Assistance publique - Hôpitaux de Paris. Started Jan 2016; status: completed.
02
Drugs
plerixafor
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT02212535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02212535.